CN100540559C - 类脂化合物调节剂及其用途 - Google Patents

类脂化合物调节剂及其用途 Download PDF

Info

Publication number
CN100540559C
CN100540559C CNB2004800086261A CN200480008626A CN100540559C CN 100540559 C CN100540559 C CN 100540559C CN B2004800086261 A CNB2004800086261 A CN B2004800086261A CN 200480008626 A CN200480008626 A CN 200480008626A CN 100540559 C CN100540559 C CN 100540559C
Authority
CN
China
Prior art keywords
lipid
mass
parts
cyclic
cyclic tetrasaccharide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB2004800086261A
Other languages
English (en)
Chinese (zh)
Other versions
CN1768071A (zh
Inventor
奥和之
久保田伦夫
福田惠温
三宅俊雄
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hayashibara Seibutsu Kagaku Kenkyujo KK
Original Assignee
Hayashibara Seibutsu Kagaku Kenkyujo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hayashibara Seibutsu Kagaku Kenkyujo KK filed Critical Hayashibara Seibutsu Kagaku Kenkyujo KK
Publication of CN1768071A publication Critical patent/CN1768071A/zh
Application granted granted Critical
Publication of CN100540559C publication Critical patent/CN100540559C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CNB2004800086261A 2003-04-03 2004-03-24 类脂化合物调节剂及其用途 Expired - Fee Related CN100540559C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP100408/2003 2003-04-03
JP2003100408 2003-04-03

Publications (2)

Publication Number Publication Date
CN1768071A CN1768071A (zh) 2006-05-03
CN100540559C true CN100540559C (zh) 2009-09-16

Family

ID=33156723

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2004800086261A Expired - Fee Related CN100540559C (zh) 2003-04-03 2004-03-24 类脂化合物调节剂及其用途

Country Status (7)

Country Link
US (2) US20060276432A1 (cg-RX-API-DMAC7.html)
EP (1) EP1616873B1 (cg-RX-API-DMAC7.html)
JP (1) JP4893981B2 (cg-RX-API-DMAC7.html)
CN (1) CN100540559C (cg-RX-API-DMAC7.html)
DE (1) DE602004015966D1 (cg-RX-API-DMAC7.html)
TW (1) TW200501964A (cg-RX-API-DMAC7.html)
WO (1) WO2004089964A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107613968A (zh) * 2015-11-19 2018-01-19 欣耀生医股份有限公司 预防或治疗脂肪肝的药物组合物

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005007171A1 (ja) * 2003-07-18 2005-01-27 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo ミネラル吸収促進剤及びその用途
JPWO2007034748A1 (ja) * 2005-09-22 2009-03-26 株式会社林原生物化学研究所 腸管免疫調節剤
JP2007267618A (ja) * 2006-03-30 2007-10-18 Mukogawa Gakuin ケーキ
JP2010053122A (ja) * 2008-07-31 2010-03-11 Hayashibara Biochem Lab Inc 脂質合成阻害剤
WO2010088222A2 (en) * 2009-01-27 2010-08-05 World Force Technologies, Llc A high molecular weight polysaccharide that binds and inhibits virus
JP2010215544A (ja) * 2009-03-13 2010-09-30 Hiroshima Univ 血管新生抑制剤、これを含有する医薬、血管新生抑制剤を産生させる整腸剤、並びに、血管新生抑制剤の投与方法
JP2014185088A (ja) * 2013-03-22 2014-10-02 Sunstar Inc 経口組成物、脂肪細胞分化抑制剤および飲食品
JP7136765B2 (ja) * 2017-03-24 2022-09-13 株式会社林原 オートファジー誘導剤とその用途
FR3087339A1 (fr) * 2018-10-22 2020-04-24 Nexira Composition pour traiter le surpoids et/ou l'obesite
JP7595018B2 (ja) 2019-10-04 2024-12-05 ナガセヴィータ株式会社 環状四糖を含有する糖組成物とその用途並びに製造方法
JP7741642B2 (ja) * 2021-03-31 2025-09-18 ナガセヴィータ株式会社 アルコール飲料、及び、アルコール飲料の苦味を抑制する方法
US20260174110A1 (en) * 2022-10-28 2026-06-25 Nagase Viita Co., Ltd. Composition for improving mouthfeel, food/beverage product composition and method for producing same, and method for improving mouthfeel

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1284286A1 (en) 2000-05-22 2003-02-19 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Alpha-isomaltosyltransferase, process for producing the same and use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6094912A (ja) * 1983-10-28 1985-05-28 Masashige Suzuki 体内中性脂肪低減剤
JPH07115934A (ja) * 1993-10-22 1995-05-09 Hairu:Kk 痩身用食品
JPH08283154A (ja) * 1995-04-12 1996-10-29 Nippon Shinyaku Co Ltd 脂質代謝改善剤
US5786196A (en) * 1995-06-12 1998-07-28 The United States Of America As Represented By The Secretary Of Agriculture Bacteria and enzymes for production of alternan fragments
TWI312369B (en) 2000-08-01 2009-07-21 Hayashibara Biochem Lab A-isomaltosylglucosaccharide synthase,process for producing the same and use thereof
EP1380595A4 (en) * 2001-03-09 2007-08-29 Hayashibara Biochem Lab BRANCHED CYCLIC TETRASACCHARIDE AND PROCESS FOR PRODUCING THE SAME
JP2003160595A (ja) * 2001-11-20 2003-06-03 Hayashibara Biochem Lab Inc 糖誘導体

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1284286A1 (en) 2000-05-22 2003-02-19 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Alpha-isomaltosyltransferase, process for producing the same and use thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107613968A (zh) * 2015-11-19 2018-01-19 欣耀生医股份有限公司 预防或治疗脂肪肝的药物组合物

Also Published As

Publication number Publication date
US20080214499A1 (en) 2008-09-04
US20060276432A1 (en) 2006-12-07
EP1616873A4 (en) 2007-01-10
CN1768071A (zh) 2006-05-03
US8940715B2 (en) 2015-01-27
WO2004089964A1 (ja) 2004-10-21
TWI330085B (cg-RX-API-DMAC7.html) 2010-09-11
JP4893981B2 (ja) 2012-03-07
WO2004089964A8 (ja) 2004-12-29
EP1616873A1 (en) 2006-01-18
EP1616873B1 (en) 2008-08-20
TW200501964A (en) 2005-01-16
JPWO2004089964A1 (ja) 2006-07-06
DE602004015966D1 (de) 2008-10-02

Similar Documents

Publication Publication Date Title
US8940715B2 (en) Lipid-regulating agent and use thereof
JP5535456B2 (ja) 食物繊維と希少糖を含む生体機能改善組成物。
JP5270058B2 (ja) 栄養性の改良されたイヌリン製品
EP2156751B1 (en) Novel sweetener having sugar-like taste and production method and use of the same
JP4702745B2 (ja) ミネラル吸収促進剤及びその用途
JP6475610B2 (ja) 抗生活習慣病用剤及びそれを含んでなる経口組成物
JP5876205B2 (ja) Ｄ−ソルボースからなる甘味料におけるｄ−ソルボースの甘味の不足や、甘味の持続を改良する方法
WO2006101118A1 (ja) D-プシコースの血糖値日内異常上昇抑制の用途
KR102303570B1 (ko) 에너지 소비의 촉진 및/또는 에너지 소비 기능 저하의 치료 및/또는 예방제, 또는 방법
EP2754444A1 (en) Composition for improving in vivo metabolism parameter
JP4048166B2 (ja) 血糖値上昇抑制剤及び体脂肪蓄積抑制剤並びに食用材料
US8722614B2 (en) Adiponectin production enhancer
JP2009286703A (ja) Ｄ−タガトースを有効成分とする体脂肪蓄積改善剤およびメタボリックシンドローム改善剤
JP2009161522A (ja) 腎障害抑制剤
JP4746281B2 (ja) 生体内脂質調節剤
CN118805891B (zh) 一种抑制脂肪吸收、控制体重的组合物及其制备方法
JP2011012005A (ja) 高脂血症改善剤
EP1559425A1 (en) Peroral preparation for prevention of or treatment for atopic dermatitis
JP2009254242A (ja) 砂糖様味質をもつ新規甘味料、その製造法および用途
JP5943516B2 (ja) Ｄ−ソルボースを有効成分とする生体機能改善用甘味料
WO2006013929A1 (ja) カルシウム吸収促進組成物
JPH10313822A (ja) 腸内細菌叢改善剤及びそれを含有する組成物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20090916

Termination date: 20180324

CF01 Termination of patent right due to non-payment of annual fee